Germani, M. M., Borelli, B., Hashimoto, T., Nakamura, Y., Bottelli, A., Battaglin, F., Lonardi, S., Salvatore, L., Stahler, A., Shitara, K., Venook, A. P., Oki, E., Muro, K., Ugolini, C., Soeda, J., Pietrantonio, F., Lenz, H., Modest, D. P., Yoshino, T., Cremolini, C. (2025). The prognostic and predictive role of HER2 amplification/overexpression and
            <i>HER2</i>
            mutations in metastatic colorectal cancer treated with first-line chemotherapy plus bevacizumab/anti-EGFRs: An individual patient data pooled analysis of eight randomized trials.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3537